- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Koda-Kimble reelected to USP Board of Trustees
By UCSF School of Pharmacy Editorial Staff / Tue Mar 22, 2005
Mary Anne Koda-Kimble, PharmD, dean of the School of Pharmacy, University of California, San Francisco has been reelected to the United States Pharmacopeia (USP) Board of Trustees. Her second term begins March 2005 and ends March 2010.
USP is a nonprofit, nongovernmental organization that sets manufacturing standards for medicines, dietary supplements, and other health care products. It also creates and shares information about these products to help ensure their appropriate use by people worldwide.
As a trustee, Koda-Kimble is one of a 12-member body that guides USP finances and strategic plans. Of the 8 elected members, Koda-Kimble is one of two trustees who represent the pharmaceutical sciences.
"This newly elected Board of Trustees will be crucial for USP's growth in the next five years," said Roger L. Williams, MD, executive vice president and chief executive officer for USP. "Each member is well respected within our industry, and USP will greatly benefit from their individual and collective expertise."
"As a nonprofit, nongovernmental body that does its work through volunteer experts, USP has become recognized as a credible, non-partisan resource. As one of its legions of volunteers, I have been privileged to participate in USP's growth and influence over these past five years," said Koda-Kimble.
"I have witnessed an unprecedented transition in USP's scope of work and its impact on public health. USP's highly regarded expertise in setting quality standards for US drugs is having increasing influence globally, where issues of counterfeit or sub-quality medicines are more common. This work has been particularly important in underdeveloped countries. In my view, USP's work is becoming ever more relevant to the delivery of the best pharmaceutical care in the promotion of global health, but we are not yet finished with the transition. This is why I am so enthusiastic about continuing my service on the USP Board of Trustees."
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.